We are live on
!
Find out more
EEG
E.E. Geduld Portfolio holdings
AUM
$178M
1-Year Est. Return
29.34%
This Fund
S&P 500
This Quarter
Est. Return
+7.42%
1 Year Est. Return
+29.34%
3 Year Est. Return
+59.91%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$207M
AUM Growth
+$43.3M
(+26%)
Cap. Flow
+$4.36M
Cap. Flow
% of AUM
2.1%
Top 10 Holdings %
Top 10 Hldgs %
41.81%
Holding
434
New
117
Increased
50
Reduced
37
Closed
98
Avg Time Held Equity + Options
1.2
quarters
Top 10 Avg Time Held Equity + Options
0.5
quarters
Top 20 Avg Time Held Equity + Options
0.9
quarters
Avg Time Held Equity only
1.2
quarters
Top 10 Avg Time Held Equity only
0.9
quarters
Top 20 Avg Time Held Equity only
1.1
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ARIA
Ariad Pharmaceuticals Inc
ARIA
|
+$4.51M |
| 2 |
3D Systems Corp
DDD
|
+$1.4M |
| 3 |
Ciena
CIEN
|
+$953K |
| 4 |
Vince Holding Corp
VNCE
|
+$906K |
| 5 |
Lennar Class A
LEN
|
+$886K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PCYC
PHARMACYCLICS INC
PCYC
|
+$2.37M |
| 2 |
Infoblox Inc
BLOX
|
+$1.46M |
| 3 |
Guidewire Software
GWRE
|
+$942K |
| 4 |
Puma Biotechnology
PBYI
|
+$880K |
| 5 |
QLIK
QLIK TECHNOLOGIES INC COM STK (DE)
QLIK
|
+$856K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 41.04% |
| 2 | Financials | 25.83% |
| 3 | Healthcare | 10.16% |
| 4 | Consumer Discretionary | 6.24% |
| 5 | Technology | 5.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
176
ProShares UltraShort Financials
SKF
$11.6M
| $174K | 0.08% |
+156
| New | +$192K |
2013 Q4
0 quarters
|
|
|
ELGX
177
DELISTED
Endologix Inc
ELGX
| $174K | 0.08% |
1,000
| – | – |
2013 Q2
2 quarters
|
|
|
NSPH
178
DELISTED
NANOSPHERE INC. COM NEW
NSPH
| $172K | 0.08% |
3,750
| – | – |
2013 Q2
2 quarters
|
|
179
CALL
Hovnanian Enterprises
HOV
$617M
| $166K | 0.08% |
1,000
| – | – |
2013 Q2
2 quarters
|
|
|
DMK
180
DELISTED
DMK Pharmaceuticals Corporation Common Stock
DMK
| $160K | 0.08% |
+357
| New | +$156K |
2013 Q4
0 quarters
|
|
|
PRKR
181
DELISTED
Parkervision Inc
PRKR
| $159K | 0.08% |
+3,500
| New | +$135K |
2013 Q4
0 quarters
|
|
182
Pure Cycle
PCYO
$271M
| $158K | 0.08% |
25,000
+15,000
| +150% | +$92.4K |
2013 Q2
2 quarters
|
|
183
OraSure Technologies
OSUR
$272M
| $157K | 0.08% |
+25,000
| New | +$157K |
2013 Q4
0 quarters
|
|
|
ECTE
184
DELISTED
ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE)
ECTE
| $157K | 0.08% |
50,000
| – | – |
2013 Q2
2 quarters
|
|
|
CHTP
185
DELISTED
CHELSEA THERAPEUTICS INT'L LTD
CHTP
| $155K | 0.07% |
35,000
-15,000
| -30% | -$50.7K |
2013 Q2
2 quarters
|
|
186
FormFactor
FORM
$10.2B
| $150K | 0.07% |
+25,000
| New | +$143K |
2013 Q4
0 quarters
|
|
|
EBIX
187
PUT
DELISTED
Ebix Inc
EBIX
| $147K | 0.07% |
+10,000
| New | +$128K |
2013 Q4
0 quarters
|
|
|
HDNG
188
DELISTED
Hardinge Inc
HDNG
| $145K | 0.07% |
10,000
| – | – |
2013 Q2
2 quarters
|
|
|
FCSC
189
DELISTED
Fibrocell Science Inc.
FCSC
| $142K | 0.07% |
+2,333
| New | +$136K |
2013 Q4
0 quarters
|
|
190
DELISTED
Bank Of America Corporation Ws B
BAC.WS.B
| $135K | 0.07% |
175,000
| – | – |
2013 Q2
2 quarters
|
|
191
Fortress Biotech
FBIO
$70.4M
| $132K | 0.06% |
3,333
+1,666
| +100% | +$64.3K |
2013 Q2
2 quarters
|
|
192
Century Casinos
CNTY
$23.3M
| $130K | 0.06% |
+25,000
| New | +$136K |
2013 Q4
0 quarters
|
|
193
DELISTED
Christopher & Banks Corporation
CBK
| $128K | 0.06% |
+15,000
| New | +$101K |
2013 Q4
0 quarters
|
|
194
DELISTED
Emcore Corp
EMKR
| $128K | 0.06% |
+2,500
| New | +$126K |
2013 Q4
0 quarters
|
|
195
Transact Technologies
TACT
$45.9M
| $125K | 0.06% |
+10,000
| New | +$130K |
2013 Q4
0 quarters
|
|
|
JMBA
196
DELISTED
Jamba, Inc.
JMBA
| $124K | 0.06% |
+10,000
| New | +$116K |
2013 Q4
0 quarters
|
|
|
SWC
197
DELISTED
Stillwater Mining Co
SWC
| $123K | 0.06% |
+10,000
| New | +$113K |
2013 Q4
0 quarters
|
|
198
CALL
Xerox
XRX
$356M
| $122K | 0.06% |
3,795
| – | – |
2013 Q3
1 quarter
|
|
|
SRNE
199
DELISTED
Sorrento Therapeutics, Inc.
SRNE
| $122K | 0.06% |
+15,000
| New | +$132K |
2013 Q4
0 quarters
|
|
200
iShares MSCI Japan ETF
EWJ
$23.7B
| $121K | 0.06% |
+2,500
| New | +$119K |
2013 Q4
0 quarters
|
|
Similar funds
BC
PFM
SRP
CF
SA
WSA
SIG
VWM
E.E. Geduld's Q4 2013 Portfolio in Review
As of Q4 2013, E.E. Geduld held 434 positions worth $207M, up 26% from $164M the previous quarter. Its ten largest holdings account for 42% of the portfolio.
E.E. Geduld's Q4 2013 filing shows 117 new, 50 increased, 37 reduced and 98 closed positions. Its largest new stake was Ariad Pharmaceuticals Inc: 835,100 shares worth $5.7M. The largest sale was PHARMACYCLICS INC, an estimated $2.37M.
By sector, the portfolio is most concentrated in Miscellaneous at 41% of assets, up from 34% a quarter earlier, followed by Financials and Healthcare.
- E.E. Geduld's largest Q4 2013 buy was Ariad Pharmaceuticals Inc: 835,100 shares worth $5.7M.
- E.E. Geduld added most to Hess in Q4 2013, an estimated $812K increase.
- E.E. Geduld's biggest Q4 2013 reduction was PHARMACYCLICS INC, cutting an estimated $2.37M.
- E.E. Geduld fully exited Infoblox Inc in Q4 2013, selling an estimated $1.46M.
- E.E. Geduld's ten largest holdings make up 42% of its $207M portfolio in Q4 2013.
- E.E. Geduld opened 117 new positions and closed 98 in Q4 2013.
- E.E. Geduld's portfolio value rose 26% quarter-over-quarter to $207M.
Based on E.E. Geduld's 13F filing for Q4 2013, filed 23 Jan 2014.